Contrary to adult, neonatal rats show pronounced brain uptake of corticosteroids

Drug Metabolism and Disposition

Volumn 34, Issue 6, 2006, Pages 939-942

  Arya, Vikram ^a   Demarco, Vincent G ^b   Issar, Manish ^a,c   Hochhaus, Günther ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b University of Missouri   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PRODRUG; TRIAMCINOLONE ACETONIDE;

ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG DOSE REGIMEN; EX VIVO STUDY; HORMONE TRANSPORT; LOW DRUG DOSE; MEMBRANE PERMEABILITY; NEUROTOXICITY; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ADRENAL CORTEX HORMONES; ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; BRAIN; INTUBATION, INTRATRACHEAL; LIVER; RATS; RATS, INBRED F344; RECEPTORS, GLUCOCORTICOID; TIME FACTORS; TRIAMCINOLONE ACETONIDE;

ANIMALIA;

EID: 33646778803     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.007419     Document Type: Article

References (28)

1. Arya V, Issar M, Wang Y, Talton JD, and Hochhaus G (2005) Brain permeability of inhaled corticosteroids. J Pharm Pharmacol 57:1159-1167.
2. Csaba G and Inczefi-Gonda A (2000) A study of the liver glucocorticoid receptor binding capacity in newborn rat. Acta Physiol Hung 87:139-143.
3. Georgieff MK, Mammel MC, Mills MM, Gunter EW, Johnson DE, and Thompson TR (1989) Effect of postnatal steroid administration on serum vitamin A concentrations in new born infants with respiratory compromise. J Pediatr 114:301-304.
4. Groneck P, Reuss D, Gotze-Speer B, and Speer CP (1993) Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk for chronic lung disease. J Pediatr 122:938-944.
5. Gutmann E, Lojda Z, and Teisinger J (1976) Changes of acid phosphatase activity of fast and slow rat muscles during ontogenetic development. Histochemistry 49:227-236.
6. Halliday HL (2004) Postnatal steroids and chronic lung disease in the newborn. Paediatr Respir Rev 5 (Suppl 1):S245-S248.
7. Hochhaus G, Gonzalez-Rothi R, Lukyanov A, Derendorf H, Schreier H, and Dalla Costa T (1995) Assessment of glucocorticoid lung targeting by ex vivo receptor binding studies in rats. Pharm Res (NY) 12:134-137.
8. Jette L, Murphy GF, Leclerc JM, and Beliveau R (1995) Interaction of drugs with P-glycoprotein in brain capillaries. Biochem Pharmacol 50:1701-1709.
9. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, and de Kloet ER (2001) Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology 142:2686-2694.
10. Mammel MC, Green TP, Johnson DE, and Thompson TR (1983) Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1:1356-1358.
11. Matheny CJ, Ali RY, Yang X, and Pollack GM (2004) Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues. Drug Metab Dispos 32:1008-1014.
12. Matsuoka Y, Okazaki M, Kitamura Y, and Taniguchi T (1999) Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J Neurobiol 39:383-392.
13. Mei Q, Richards K, Strong-Basalyga K, Fauty SE, Taylor A, Yamazaki M, Prueksaritanont T, Lin JH, and Hochman J (2004) Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat P-glycoproteins mdr1a/1b and cytochrome P450 3A1/2. J Pharm Sci 93:2488-2496.
14. Meijer OC, de Lange EC, Breimer DD, de Boer AG, Workel JO, and de Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 139:1789-1793.
15. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, Jolesz FA, and Volpe JJ (2001) Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 107:217-221.
16. Nicholl RM, Greenough A, King M, Cheeseman P, and Gamsu HR (2002) Growth effects of systemic versus inhaled steroids in chronic lung disease. Arch Dis Child Fetal Neonatal Ed 87:F59-F61.
17. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, and Jackson BG, Weaver RG 3rd, and Dillard RG (1999) Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 104:15-21.
18. Perloff MD, von Moltke LL, and Greenblatt DJ (2004) Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats. Xenobiotica 34:133-150.
19. Sapolsky RM and Meaney MJ (1986) Maturation of adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 396:64-76.
20. Seree E, Villard PH, Hever A, Guigal N, Puyoou F, Charvet B, Point-Scomma H, Lechevalier E, Lacarelle B, and Barra Y (1998) Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals. Biochem Biophys Res Commun 252:392-395.
21. Suarez S, Gonzalez-Rothi RJ, Schreier H, and Hochhaus G (1998) Effect of dose and release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm Res (NY) 15:1461-1465.
22. Turrel MO, Propper AY, and Adessi GL (1985) Characterization of a glucocorticoid receptor in neonatal rat mammary gland. J Steroid Biochem 22:431-434.
23. Ueda K, Taguchi Y, and Morishima M (1997) How does P-glycoprotein recognize its substrates? Semin Cancer Biol 8:151-159.
24. Uhr M, Holsboer F, and Muller MB (2002) Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol 14:753-759.
25. Williams O and Greenough A (2003) Post-natal corticosteroid use. Eur J Pediatr 162:613-615.
26. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, and Lien YJ (1998) Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101:E7.
27. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, and Tsai CH (2004) Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350:1304-1313.
28. Yeoh GC and Morgan EH (1974) Albumin and transferrin synthesis during development in the rat. Biochem J 144:215-224.